GEN Exclusives

More »

New Products

More »
Feb 1, 2014 (Vol. 34, No. 3)

Peptides International

Click Image To Enlarge +

Peptide Toxin

μ-SLPTX-Ssm6a, a 46-residue peptide toxin derived from the Chinese redheaded centipede (Scolopendra subspinipes mutilans), is now commercially available. It has implications for drug discovery because it potently and selectively blocks the human NaV1.7 channel, which is currently a target of interest for pain management. (Because loss-of-function mutations in the human voltage-gated sodium channel NaV1.7 result in a congenital indifference to pain, selective inhibitors of NaV1.7 are likely to be powerful analgesics for treating a broad range of pain conditions. In rodent pain models, NaV1.7’s analgesic efficacy has been found to exceed that of morphine.) This peptide toxin has no homology to previously reported NaV1.7 blockers such as ProTx-II.

Related To This Company

Products

Advertisements

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?